References
- Weisstuch JM, Dworkin L D. Does essential hypertension cause end-stage renal disease?. Kidney Int 1992; 41(suppl 36)33–37
- Mogensen CE. Microalbuminuria as a predictor of clinical diabetic nephropathy. Kidney Int 1987; 31: 673–689
- Rudberg S, Persson B, Dahlquist G. Increased glomerular filtration rate as a predictor of diabetic nephropathy - An 8-year prospective study. Kidney Int 1992; 41: 822–828
- Forsblom CM, Groop P, Ekstrand A. Predictive value of microalbuminuria in patients with insulin-dependent diabetes of long duration. Br Med J 1992; 305: 1051–1053
- Marshall SM. Screening for microalbuminuria: which measurement?. Diabetic Med 1991; 8: 706–711
- Ellis D, Coonrod BA, Dorman JS, Kelsey SF, Becker DJ, Avner ED. Choice of urine sample predictive of microalbuminuria in patients with insulin-dependent diabetes mellitus. Am J Kidney Dis 1989; 13: 321–328
- Gould MM, Ali V, Goubet SA, Yudkin JS, Haines A P. Microalbuminuria: associations with height and sex in non-diabetic subjects. Br Med J 1993; 306: 240–242
- Rambausek M, Fliser D, Ritz E. Albuminuria of hypertensive patients. Clin Nephrol 1992; 38(suppl 1)40–45
- Cerasola G, Cottone S, Ignoto G, Grasso L, Mangano MT, Carapelle E, Nardi E, Andronico G, Fulantelli MA, Marcellino T, Seddio G. Micro-albuminuria as a predictor of cardiovascular damage in essential hypertension. J Hypertens 1989; 7(suppl 6)S332–S333
- Giaconi S, Levanti C, Fommei E, Innocenti F, Seghieri G, Palla L, Palombo C, Ghione S. Microalbuminuria and casual and ambulatory blood pressure monitoring in normotensives and in patients with borderline and mild essential hypertension. Am J Hypertens 1989; 2: 259–261
- Bianchi S, Bigazzi R, Baldari G. Microalbuminuria in patients with essential hypertension: effects of several antihypertensive drugs. Am J Med 1992; 93: 525–528
- Schmieder RE, Ruddel H, Schlebusch H, Rockstroh J, Schachinger H, Schulte W. Impact of antihypertensive therapy with Isradipine and Metoprolol on early markers of hypertensive nephropathy. Am J Hypertens 1992; 5: 318–321
- Reams GP, Hamory A, Lau A. Effect of nifedipine on renal function in patients with essential hypertension. Hypertension 1988; 11: 452–456
- Mathiesen ER, Hommel E, Giese J, Parving H. Efficacy of captopril in postponing nephropathy in normotensive insulin dependent diabetic patients with microalbuminuria. Br Med J 1991; 303: 81–86
- Anderson S, Brenner M. The role of intraglomerular pressure in the initiation and progression of renal disease. J Hypertens 1986; 4(suppl 5)236–238
- Anderson S, Rennke HG. Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. J Clin Invest 1986; 77: 1993–2000
- Yoshioka T, Shiraga H, Yoshida Y, Fogo A, Glick AD, Deen WM, Hoyer JR, Ichikawa I. “Intact nephrons” as the primary origin of proteinuria in chronic renal disease. Study in the rat model of subtotal nephrectomy. J Clin Invest 1988; 82: 1614–1623
- Ruilope LM, Alcazar JM, Hernandez E, Moreno F, Martinez MA, Rodicio J L. Does an adequate control of blood pressure protect the kidney in essential hypertension?. J Hypertens 1990; 8: 525–531
- Feld L, Liew JB, Brentjens JR, Boylan J W. Renal lesions and proteinuria in the spontaneously hypertensive rat made normotensive by treatment. Kidney Int 1981; 20: 606–614
- Borch-Johnsen K, Kreiner S. Proteinuria: value as predictor of cardiovascular mortality in insulin dependent diabetes mellitus. Br Med J 1987; 294: 1651–1654
- Jones SL, Close CF, Mattock MB, Jarrett RJ, Keen H. Plasma lipid and coagulation factor concentrations in insulin dependent diabetics with microalbuminuria. Br Med J 1989; 298: 487–490
- Jensen T, Knudsen J, Feldt-Rasmussen B, Deckert T. Features of endothelial dysfunction in early diabetic nephropathy. Lancet 1989; 1: 461–463
- Yudkin JS, Forrest RD. Microalbuminuria as predictor of vascular disease in non-diabetic subjects. Lancet 1988; 2: 530–533
- Samuelsson O, Wilhelmsen L, Elmfeldt D, Pennert K, Wedel H, Wikstrand J, Berglund G. Predictors of cardiovascular morbidity in treated hypertension: results from the primary preventive trial in Gotebord, Sweden. J Hypertens 1985; 3: 167–176
- Bigazzi R, Bianchi S, Campese VM, Baldari G. Prevalence of microalbuminuria in a large population of patients with mild to moderate essential hypertension. Nephron 1992; 61: 94–97